RE:2020, I don't think soGunnerG:
“Odd “ that you misread what I write. 2020 will begin the long rise of the sp because of the potential value of PBI-4050 in the worldwide marketplace for fibrosis indications by getting their foot in the door into the U.K. market for Alstrom patients, the 2024 year will see the “maturity” of 4050 in many fibrotic indications. Remember, 4050 REVERSES fibrosis in five major organs and that is no small feat as no other drug can currently make that claim.
Pay attention Mr. G, I won’t always be around to explain.
Funny how you read but don’t comprehend... I guess FUD pumpers (like yourself) aren’t allowed to think for themselves or go off-script...